Biohaven (BHVN) Cash from Operations (2021 - 2026)
Biohaven's (BHVN) quarterly Cash from Operations came in at 149918000.0 in Q1 2026, up 9.21% year-on-year from 137276436.71 in Q1 2025, and down 14.74% quarter-over-quarter from 130662000.0 in Q4 2025.
Biohaven (BHVN) Cash from Operations (2021 - 2026) Analysis & Trends
Biohaven has disclosed Cash from Operations across 6 years of filings, most recently posting 149918000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 149918000.0, up 9.21% year-over-year; the trailing twelve-month figure through Mar 2026 was 594232000.0 (up 7.86% YoY), and the FY2025 annual result was 609438000.0, down 4.63% from the prior year.
- Cash from Operations came in at 149918000.0 for Q1 2026 at Biohaven, down from 130662000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 44393000.0 in Q2 2023 to a low of 170742000.0 in Q4 2024.
- The 5-year median for Cash from Operations is 114881000.0 (2023), against an average of 115954294.12.
- Across the five-year window, Cash from Operations soared 34.61% in 2023 and slumped 277.98% in 2024, its largest moves.
- Biohaven's Cash from Operations stood at 75407000.0 in 2022, then sank by 52.35% to 114881000.0 in 2023, then sank by 48.63% to 170742000.0 in 2024, then gained by 23.47% to 130662000.0 in 2025, then dropped by 14.74% to 149918000.0 in 2026.
- The last three Cash from Operations figures came in at 149918000.0 (Q1 2026), 130662000.0 (Q4 2025), and 145716000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | -149.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -149.92 Mn |
| Mar 31, 2026 | -149.92 Mn |
| Dec 31, 2025 | -130.66 Mn |
| Dec 31, 2025 | -130.66 Mn |
| Sep 30, 2025 | -145.72 Mn |
| Sep 30, 2025 | -145.72 Mn |
| Jun 30, 2025 | -167.94 Mn |
| Jun 30, 2025 | -167.94 Mn |
| Mar 31, 2025 | -165.12 Mn |
| Mar 31, 2025 | -165.12 Mn |
| Dec 31, 2024 | -170.74 Mn |
| Dec 31, 2024 | -170.74 Mn |
| Sep 30, 2024 | -141.28 Mn |
| Sep 30, 2024 | -141.28 Mn |
| Jun 30, 2024 | -167.80 Mn |
| Jun 30, 2024 | -167.80 Mn |
| Mar 31, 2024 | -102.64 Mn |
| Mar 31, 2024 | -102.64 Mn |
| Dec 31, 2023 | -114.88 Mn |
| Dec 31, 2023 | -114.88 Mn |